International long‐term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years
To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0–19. Based on temporal trends during 1978–2007 in 24 populations, lymphoid leukemia and myelo...
Saved in:
Published in | International journal of cancer Vol. 138; no. 8; pp. 1862 - 1874 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
15.04.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0–19. Based on temporal trends during 1978–2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non‐Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003–2007 in 54 populations varied about 10‐fold, with rates highest in US white Hispanics (50.2 per million person‐years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non‐Hodgkin lymphoma rates varied 30‐fold, with very high rates in sub‐Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian‐Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15‐fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age‐specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world‐wide, except for non‐Hodgkin lymphoma. A systematic world‐wide approach comparing postulated etiologic factors in low‐ versus high‐risk populations may help clarify the etiology of these childhood malignancies.
What's new?
This first study to assess systematically long‐term (1978–2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non‐Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003–2007 age‐adjusted incidence rates spanning five continents for non‐Hodgkin lymphoma have varied 30‐fold, Hodgkin lymphoma 15‐fold, lymphoid leukemia 10‐fold, and myeloid leukemia only 5‐fold. |
---|---|
AbstractList | To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤ 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7). Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies.To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤ 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7). Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies. To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates ( less than or equal to 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long-term (1978-2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non-Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003-2007 age-adjusted incidence rates spanning five continents for non-Hodgkin lymphoma have varied 30-fold, Hodgkin lymphoma 15-fold, lymphoid leukemia 10-fold, and myeloid leukemia only 5-fold. To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (?10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long-term (1978-2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non-Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003-2007 age-adjusted incidence rates spanning five continents for non-Hodgkin lymphoma have varied 30-fold, Hodgkin lymphoma 15-fold, lymphoid leukemia 10-fold, and myeloid leukemia only 5-fold. To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0–19. Based on temporal trends during 1978–2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non‐Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003–2007 in 54 populations varied about 10‐fold, with rates highest in US white Hispanics (50.2 per million person‐years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non‐Hodgkin lymphoma rates varied 30‐fold, with very high rates in sub‐Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian‐Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15‐fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age‐specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world‐wide, except for non‐Hodgkin lymphoma. A systematic world‐wide approach comparing postulated etiologic factors in low‐ versus high‐risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long‐term (1978–2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non‐Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003–2007 age‐adjusted incidence rates spanning five continents for non‐Hodgkin lymphoma have varied 30‐fold, Hodgkin lymphoma 15‐fold, lymphoid leukemia 10‐fold, and myeloid leukemia only 5‐fold. To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤ 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7). Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies. |
Author | Linet, Martha S. Check, David Mbulaiteye, Sam M. Brown, Linda M. Ostroumova, Evgenia Landgren, Annelie Devesa, Susan S. |
Author_xml | – sequence: 1 givenname: Martha S. surname: Linet fullname: Linet, Martha S. organization: National Cancer Institute, NIH – sequence: 2 givenname: Linda M. surname: Brown fullname: Brown, Linda M. organization: RTI International – sequence: 3 givenname: Sam M. surname: Mbulaiteye fullname: Mbulaiteye, Sam M. organization: National Cancer Institute, NIH – sequence: 4 givenname: David surname: Check fullname: Check, David organization: National Cancer Institute, NIH – sequence: 5 givenname: Evgenia surname: Ostroumova fullname: Ostroumova, Evgenia organization: National Cancer Institute, NIH – sequence: 6 givenname: Annelie surname: Landgren fullname: Landgren, Annelie organization: National Cancer Institute, NIH – sequence: 7 givenname: Susan S. surname: Devesa fullname: Devesa, Susan S. organization: National Cancer Institute, NIH |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26562742$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1uEzEUhS1URNPCghdAltjAYlr_zY-XKOInqBIbWI9sz03j4LGD7VGVXR8BxBv2SfAkhUUlEKsr3_OdoyufM3TigweEnlNyQQlhl3ZrLpiUTDxCC0pkWxFG6xO0KBqpWsqbU3SW0pYQSmsinqBT1tQNawVboB8rnyF6lW3wymEX_PXd7feyGnGO4IeElR9wBAM-453KM5yw9ThvoAxjB_AGcFhjB9NXGK06Otx-3G3COL_GkonNxrqhBB5ENQQHaY4s8jUkTO5uf1KJ96Bieooer5VL8Ox-nqMv795-Xn6orj69Xy3fXFVGMCqqhjUMTKOlMCC51kNDoAZVKym4HExX1oq0RNdMk7buONNdB4KvjTZaCNryc_TqmLuL4dsEKfejLTc5pzyEKfW07WrGKaX8P9BGUN7JThT05QN0G6byv-5AMcnrls2BL-6pSY8w9LtoRxX3_e9eCvD6CJgYUoqw_oNQ0s-d96Xz_tB5YS8fsMbmQ6E5Kuv-5bixDvZ_j-5XH5dHxy9BVr8_ |
CitedBy_id | crossref_primary_10_2217_fon_2017_0276 crossref_primary_10_1002_ijc_30575 crossref_primary_10_1136_bmjpo_2022_001802 crossref_primary_10_1007_s12672_022_00465_6 crossref_primary_10_1080_0284186X_2020_1738546 crossref_primary_10_1007_s10552_020_01267_3 crossref_primary_10_17533_udea_iatreia_50 crossref_primary_10_1016_j_ijheh_2018_08_004 crossref_primary_10_1186_s13000_018_0693_0 crossref_primary_10_1016_j_sste_2024_100698 crossref_primary_10_1002_cncr_30630 crossref_primary_10_1038_s41416_024_02629_3 crossref_primary_10_1371_journal_pone_0172986 crossref_primary_10_1016_j_arcmed_2016_11_017 crossref_primary_10_1007_s12094_018_1860_1 crossref_primary_10_1093_jnci_djx030 crossref_primary_10_1016_j_canep_2018_07_004 crossref_primary_10_1002_ijc_33619 crossref_primary_10_1177_2333794X17715831 crossref_primary_10_1002_ijc_32203 crossref_primary_10_1038_s41568_023_00584_4 crossref_primary_10_1016_j_ejca_2021_12_010 crossref_primary_10_1016_S1470_2045_18_30498_4 crossref_primary_10_1016_j_envres_2019_108827 crossref_primary_10_1038_s41375_020_01024_0 crossref_primary_10_3390_genes11030302 crossref_primary_10_3390_cancers13071692 crossref_primary_10_7717_peerj_18296 crossref_primary_10_1016_j_epsc_2018_01_008 crossref_primary_10_1016_j_sste_2023_100582 crossref_primary_10_1007_s00431_017_2982_0 crossref_primary_10_3390_hemato3030030 crossref_primary_10_1016_j_jncc_2022_02_001 crossref_primary_10_1186_s40359_024_01798_3 crossref_primary_10_1016_S2352_3026_17_30053_4 crossref_primary_10_1097_MPH_0000000000001105 crossref_primary_10_1080_10934529_2020_1861903 crossref_primary_10_1093_aje_kww018 crossref_primary_10_1177_09732179241304925 crossref_primary_10_1038_s41577_021_00505_2 crossref_primary_10_1080_08880018_2019_1649333 crossref_primary_10_3389_fpubh_2021_805757 crossref_primary_10_3390_ijms20030735 crossref_primary_10_1182_blood_2019004381 crossref_primary_10_1371_journal_pone_0181805 crossref_primary_10_3390_cancers15041011 crossref_primary_10_1016_j_canep_2020_101764 crossref_primary_10_1016_j_canep_2021_101965 crossref_primary_10_1016_j_leukres_2021_106585 crossref_primary_10_1186_s12885_019_6510_7 crossref_primary_10_1007_s10552_016_0817_3 crossref_primary_10_3390_ijerph14121468 crossref_primary_10_1002_hon_2776 crossref_primary_10_1016_j_phoj_2020_06_008 crossref_primary_10_1371_journal_pone_0210224 crossref_primary_10_1089_jayao_2017_0095 crossref_primary_10_1093_aje_kwz058 crossref_primary_10_1002_hon_3070 crossref_primary_10_1080_10245332_2017_1396056 crossref_primary_10_1177_1010428317697573 crossref_primary_10_18632_aging_203116 crossref_primary_10_1002_bies_202400033 crossref_primary_10_1002_cncr_30129 crossref_primary_10_1016_j_canep_2020_101851 crossref_primary_10_1186_s12885_016_2689_z crossref_primary_10_3390_cancers15143653 |
Cites_doi | 10.1002/pbc.22383 10.1016/j.ejca.2006.06.001 10.1093/jnci/66.6.1192 10.1038/sj.leu.2402252 10.1016/j.eururo.2012.02.054 10.1146/annurev-publhealth-031912-114350 10.1002/ijc.2910080203 10.1016/S0140-6736(01)05581-7 10.1016/j.cbi.2012.01.007 10.1016/S0140-6736(04)17550-8 10.1038/bjc.1996.219 10.1111/j.1365-3016.1990.tb00654.x 10.1002/ijc.2910320609 10.1002/ajh.23187 10.3322/caac.21219 10.1093/jnci/djg064 10.1093/aje/141.4.300 10.1002/ijc.28222 10.1002/ijc.23226 10.3109/02841869209108173 10.1016/j.ctrv.2010.02.004 10.1093/jnci/85.22.1819 10.1002/cncr.23169 10.1016/j.ejca.2006.05.005 10.1002/cncr.28749 10.1016/j.ejca.2006.06.005 10.1177/030089167606200203 10.1038/bjc.1982.90 10.1002/ijc.2910610204 10.1158/1055-9965.EPI-15-0535 10.1016/j.taap.2003.12.032 10.1093/acprof:oso/9780195149616.003.0065 10.1016/j.ejca.2006.05.012 10.1046/j.1365-3016.2002.00422.x 10.1002/ijc.2910610108 10.1038/bjc.1991.98 10.1093/jnci/91.12.1051 10.1002/ijc.2910550111 |
ContentType | Journal Article |
Copyright | 2015 UICC 2015 UICC. 2016 UICC |
Copyright_xml | – notice: 2015 UICC – notice: 2015 UICC. – notice: 2016 UICC |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 |
DOI | 10.1002/ijc.29924 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts AIDS and Cancer Research Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0215 |
EndPage | 1874 |
ExternalDocumentID | 3945374081 26562742 10_1002_ijc_29924 IJC29924 |
Genre | article Research Support, U.S. Gov't, P.H.S Journal Article Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the U.S. Public Health Service of the Department of Health and Human Services. – fundername: Intramural NIH HHS |
GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4214-6262ec6b94ce93bbd60e5ea5a9439dc84cea070b52b075832b88e43fcbcb44173 |
IEDL.DBID | DR2 |
ISSN | 0020-7136 1097-0215 |
IngestDate | Thu Jul 10 17:53:49 EDT 2025 Thu Jul 10 23:44:35 EDT 2025 Sun Jul 13 04:17:51 EDT 2025 Thu Apr 03 07:06:54 EDT 2025 Thu Apr 24 23:06:56 EDT 2025 Tue Jul 01 02:28:16 EDT 2025 Wed Aug 20 07:24:42 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | myeloid leukemia childhood lymphoid leukemia non-Hodgkin lymphoma incidence trends Hodgkin lymphoma |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2015 UICC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4214-6262ec6b94ce93bbd60e5ea5a9439dc84cea070b52b075832b88e43fcbcb44173 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.29924 |
PMID | 26562742 |
PQID | 1762935723 |
PQPubID | 105430 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1785231113 proquest_miscellaneous_1764138984 proquest_journals_1762935723 pubmed_primary_26562742 crossref_primary_10_1002_ijc_29924 crossref_citationtrail_10_1002_ijc_29924 wiley_primary_10_1002_ijc_29924_IJC29924 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 15 April 2016 |
PublicationDateYYYYMMDD | 2016-04-15 |
PublicationDate_xml | – month: 04 year: 2016 text: 15 April 2016 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | International journal of cancer |
PublicationTitleAlternate | Int J Cancer |
PublicationYear | 2016 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2012; 61 2002; 16 2004; 364 2010; 54 1976; 62 2010; 36 2005; 90 1993; 85 1998 1983; 32 2006 1996; 73 1992 2012; 59 1992; 31 2008; 122 2003; 95 1981; 66 2014; 64 2015; 24 1982; 45 2004; 199 2012; 196 1971; 8 1995; 61 2006; 42 2001 2013; 34 1991; 63 1993; 55 1988; 87 2013; 133 2001; 15 2014 2013 2008; 112 1999; 91 2014; 120 1995; 141 2012; 87 1990; 4 2001; 358 e_1_2_6_51_1 e_1_2_6_32_1 e_1_2_6_30_1 Howlader N (e_1_2_6_18_1) 2014 e_1_2_6_19_1 e_1_2_6_36_1 e_1_2_6_34_1 e_1_2_6_17_1 WHO (e_1_2_6_24_1) 1992 e_1_2_6_15_1 e_1_2_6_38_1 Brunning RD (e_1_2_6_48_1) 2001 e_1_2_6_43_1 Parkin DM (e_1_2_6_13_1) 1988; 87 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_9_1 e_1_2_6_5_1 e_1_2_6_7_1 Dalmasso P (e_1_2_6_37_1) 2005; 90 e_1_2_6_49_1 e_1_2_6_3_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_26_1 e_1_2_6_47_1 e_1_2_6_52_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_50_1 e_1_2_6_14_1 e_1_2_6_35_1 Munoz N. (e_1_2_6_11_1) 1976; 62 e_1_2_6_12_1 e_1_2_6_33_1 Hjalgrim H. (e_1_2_6_53_1) 2012; 59 e_1_2_6_39_1 e_1_2_6_16_1 e_1_2_6_42_1 e_1_2_6_21_1 e_1_2_6_40_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_27_1 e_1_2_6_46_1 |
References_xml | – volume: 112 start-page: 416 year: 2008 end-page: 32 article-title: Trends in childhood cancer incidence in the U.S. (1992‐2004) publication-title: Cancer – volume: 122 start-page: 1130 year: 2008 end-page: 4 article-title: Trends in childhood acute lymphoblastic leukemia in Western Australia, 1960‐2006 publication-title: Int J Cancer – volume: 85 start-page: 1819 year: 1993 end-page: 27 article-title: Migration patterns and breast cancer risk in Asian‐American women publication-title: J Natl Cancer Inst – volume: 42 start-page: 2150 year: 2006 end-page: 69 article-title: Thyroid cancer incidence and survival among European children and adolescents (1978‐1997): Report from the Automated Childhood Cancer Information System project publication-title: Eur J Cancer – volume: 31 start-page: 275 year: 1992 end-page: 82 article-title: Lymphoma incidence in a Swedish county during 1969‐1987 publication-title: Acta Oncol – volume: 196 start-page: 59 year: 2012 end-page: 67 article-title: Perspectives on the causes of childhood leukemia publication-title: Chem Biol Interact – volume: 95 start-page: 1539 year: 2003 end-page: 44 article-title: Age‐ and sex‐specific incidence of childhood leukemia by immunophenotype in the Nordic countries publication-title: J Natl Cancer Inst – volume: 73 start-page: 1141 year: 1996 end-page: 7 article-title: Childhood leukaemias in New Zealand: time trends and ethnic differences publication-title: Br J Cancer – volume: 45 start-page: 543 year: 1982 end-page: 51 article-title: Trends in childhood leukaemia in Britain 1968‐1978 publication-title: Br J Cancer – volume: 91 start-page: 1051 year: 1999 end-page: 8 article-title: Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States publication-title: J Natl Cancer Inst – start-page: 1251 year: 2006 end-page: 68 – year: 2001 – volume: 87 start-page: 573 year: 2012 end-page: 8 article-title: Pediatric, elderly, and emerging adult‐onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa publication-title: Am J Hematol – volume: 364 start-page: 2097 year: 2004 end-page: 105 article-title: Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study publication-title: Lancet – volume: 87 start-page: 1 year: 1988 end-page: 401 article-title: International incidence of childhood cancer publication-title: IARC Sci Publ – volume: 63 start-page: 424 year: 1991 end-page: 9 article-title: Descriptive epidemiology of childhood leukaemia publication-title: Br J Cancer – volume: 54 start-page: 1009 year: 2010 end-page: 13 article-title: Trends in childhood cancer incidence and mortality in urban Shanghai, 1973‐2005 publication-title: Pediatr Blood Cancer – volume: 34 start-page: 97 year: 2013 end-page: 117 article-title: Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors publication-title: Annu Rev Public Health – volume: 55 start-page: 57 year: 1993 end-page: 62 article-title: Cancer among teenagers in Denmark, 1943‐1987 publication-title: Int J Cancer – volume: 8 start-page: 192 year: 1971 end-page: 201 article-title: Epidemiologic patterns of Hodgkin's disease publication-title: Int J Cancer – volume: 61 start-page: 165 year: 1995 end-page: 9 article-title: International patterns in the occurrence of Hodgkin's disease in children and young adult males publication-title: Int J Cancer – year: 1992 – volume: 42 start-page: 2050 year: 2006 end-page: 63 article-title: Non‐Hodgkin's lymphoma incidence and survival in European children and adolescents (1978‐1997): report from the Automated Childhood Cancer Information System project publication-title: Eur J Cancer – volume: 358 start-page: 385 year: 2001 end-page: 7 article-title: Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK publication-title: Lancet – year: 2014 – year: 1998 – volume: 59 start-page: B4485 year: 2012 article-title: On the aetiology of Hodgkin lymphoma publication-title: Dan Med J – volume: 61 start-page: 40 year: 1995 end-page: 3 article-title: Cancer incidence and mortality among teenagers in Vaud, Switzerland, 1974‐1992 publication-title: Int J Cancer – volume: 32 start-page: 703 year: 1983 end-page: 16 article-title: Childhood cancer incidence: geographical and temporal variations publication-title: Int J Cancer – volume: 64 start-page: 83 year: 2014 end-page: 103 article-title: Childhood and adolescent cancer statistics, 2014 publication-title: CA Cancer J Clin. – volume: 199 start-page: 104 year: 2004 end-page: 17 article-title: Causes of childhood leukaemia and lymphoma publication-title: Toxicol Appl Pharmacol – volume: 120 start-page: 2883 year: 2014 end-page: 92 article-title: US lung cancer trends by histologic type publication-title: Cancer – volume: 15 start-page: 1612 year: 2001 end-page: 8 article-title: Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues publication-title: Leukemia – volume: 90 start-page: 1197 year: 2005 end-page: 204 article-title: Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north‐west Italy, 1967‐2001. A report of the Childhood Cancer Registry of Piedmont publication-title: Haematologica – volume: 42 start-page: 2037 year: 2006 end-page: 49 article-title: Hodgkin's disease incidence and survival in European children and adolescents (1978‐1997): report from the Automated Cancer Information System project publication-title: Eur J Cancer – volume: 36 start-page: 286 year: 2010 end-page: 97 article-title: Aetiology of childhood leukaemia publication-title: Cancer Treat Rev – volume: 62 start-page: 157 year: 1976 end-page: 62 article-title: Prenatal exposure and carcinogenesis publication-title: Tumori – volume: 16 start-page: 210 year: 2002 end-page: 8 article-title: Childhood leukaemia in Costa Rica, 1981‐96 publication-title: Paediatr Perinat Epidemiol – volume: 66 start-page: 1191 year: 1981 end-page: 308 article-title: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today publication-title: J Natl Cancer Inst – volume: 61 start-page: 1079 year: 2012 end-page: 92 article-title: International variation in prostate cancer incidence and mortality rates publication-title: Eur Urol – volume: 141 start-page: 300 year: 1995 article-title: Graphical presentation of trends in rates publication-title: Am J Epidemiol – volume: 24 start-page: 1495 year: 2015 end-page: 506 article-title: International Variation in Female Breast Cancer Incidence and Mortality Rates publication-title: Cancer Epidemiol Biomarkers Prev – volume: 42 start-page: 2019 year: 2006 end-page: 36 article-title: Leukaemia incidence and survival in children and adolescents in Europe during 1978‐1997. Report from the Automated Childhood Cancer Information System project publication-title: Eur J Cancer – volume: 133 start-page: 2201 year: 2013 end-page: 6 article-title: Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark publication-title: Int J Cancer – volume: 4 start-page: 303 year: 1990 end-page: 24 article-title: International variations in the incidence of childhood lymphomas publication-title: Paediatr Perinat Epidemiol – year: 2013 – ident: e_1_2_6_34_1 doi: 10.1002/pbc.22383 – ident: e_1_2_6_17_1 doi: 10.1016/j.ejca.2006.06.001 – ident: e_1_2_6_4_1 doi: 10.1093/jnci/66.6.1192 – ident: e_1_2_6_14_1 – ident: e_1_2_6_36_1 doi: 10.1038/sj.leu.2402252 – ident: e_1_2_6_22_1 doi: 10.1016/j.eururo.2012.02.054 – volume: 90 start-page: 1197 year: 2005 ident: e_1_2_6_37_1 article-title: Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north‐west Italy, 1967‐2001. A report of the Childhood Cancer Registry of Piedmont publication-title: Haematologica – volume: 59 start-page: B4485 year: 2012 ident: e_1_2_6_53_1 article-title: On the aetiology of Hodgkin lymphoma publication-title: Dan Med J – ident: e_1_2_6_5_1 doi: 10.1146/annurev-publhealth-031912-114350 – ident: e_1_2_6_49_1 doi: 10.1002/ijc.2910080203 – ident: e_1_2_6_33_1 doi: 10.1016/S0140-6736(01)05581-7 – ident: e_1_2_6_3_1 doi: 10.1016/j.cbi.2012.01.007 – ident: e_1_2_6_42_1 doi: 10.1016/S0140-6736(04)17550-8 – ident: e_1_2_6_38_1 doi: 10.1038/bjc.1996.219 – ident: e_1_2_6_16_1 doi: 10.1111/j.1365-3016.1990.tb00654.x – ident: e_1_2_6_12_1 doi: 10.1002/ijc.2910320609 – ident: e_1_2_6_28_1 doi: 10.1002/ajh.23187 – volume: 87 start-page: 1 year: 1988 ident: e_1_2_6_13_1 article-title: International incidence of childhood cancer publication-title: IARC Sci Publ – ident: e_1_2_6_44_1 doi: 10.3322/caac.21219 – volume-title: International Statistical Classification of Diseases and Related Health Problems year: 1992 ident: e_1_2_6_24_1 – ident: e_1_2_6_32_1 doi: 10.1093/jnci/djg064 – ident: e_1_2_6_26_1 doi: 10.1093/aje/141.4.300 – ident: e_1_2_6_10_1 doi: 10.1002/ijc.28222 – ident: e_1_2_6_6_1 – ident: e_1_2_6_35_1 doi: 10.1002/ijc.23226 – ident: e_1_2_6_47_1 doi: 10.3109/02841869209108173 – ident: e_1_2_6_52_1 doi: 10.1016/j.ctrv.2010.02.004 – ident: e_1_2_6_9_1 doi: 10.1093/jnci/85.22.1819 – ident: e_1_2_6_20_1 – ident: e_1_2_6_39_1 doi: 10.1002/cncr.23169 – ident: e_1_2_6_30_1 doi: 10.1016/j.ejca.2006.05.005 – ident: e_1_2_6_8_1 doi: 10.1002/cncr.28749 – ident: e_1_2_6_29_1 doi: 10.1016/j.ejca.2006.06.005 – volume: 62 start-page: 157 year: 1976 ident: e_1_2_6_11_1 article-title: Prenatal exposure and carcinogenesis publication-title: Tumori doi: 10.1177/030089167606200203 – ident: e_1_2_6_41_1 doi: 10.1038/bjc.1982.90 – ident: e_1_2_6_50_1 doi: 10.1002/ijc.2910610204 – ident: e_1_2_6_23_1 doi: 10.1158/1055-9965.EPI-15-0535 – ident: e_1_2_6_7_1 – ident: e_1_2_6_25_1 – ident: e_1_2_6_19_1 – ident: e_1_2_6_51_1 doi: 10.1016/j.taap.2003.12.032 – ident: e_1_2_6_2_1 doi: 10.1093/acprof:oso/9780195149616.003.0065 – volume-title: SEER Cancer Statistics Review, 1975‐2011 year: 2014 ident: e_1_2_6_18_1 – ident: e_1_2_6_27_1 – ident: e_1_2_6_31_1 doi: 10.1016/j.ejca.2006.05.012 – ident: e_1_2_6_40_1 doi: 10.1046/j.1365-3016.2002.00422.x – ident: e_1_2_6_46_1 doi: 10.1002/ijc.2910610108 – ident: e_1_2_6_21_1 – ident: e_1_2_6_15_1 doi: 10.1038/bjc.1991.98 – ident: e_1_2_6_43_1 doi: 10.1093/jnci/91.12.1051 – volume-title: Acute myeloid leukaemia: introduction year: 2001 ident: e_1_2_6_48_1 – ident: e_1_2_6_45_1 doi: 10.1002/ijc.2910550111 |
SSID | ssj0011504 |
Score | 2.4610133 |
Snippet | To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin... To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1862 |
SubjectTerms | Adolescent Age Distribution Cancer Child Child, Preschool childhood Epidemiology Female Global Health - statistics & numerical data Global Health - trends Hodgkin lymphoma Humans Incidence Infant Infant, Newborn Leukemia Leukemia - epidemiology lymphoid leukemia Lymphoma Lymphoma - epidemiology Male Medical research myeloid leukemia non‐Hodgkin lymphoma Pediatrics Registries trends Young Adult |
Title | International long‐term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.29924 https://www.ncbi.nlm.nih.gov/pubmed/26562742 https://www.proquest.com/docview/1762935723 https://www.proquest.com/docview/1764138984 https://www.proquest.com/docview/1785231113 |
Volume | 138 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUQB8SFfSkUNCAOXFISx0kdcUIIBEhwQCBxQIpsx0WFkiLSHuDEJ4D4w34JY2eBsglxq-JJ5SSzvPHYbwjZ4IwlrBUlDhohdZgMPUfo0HcSTluREBixuDk7fHwSHpyzo4vgYoRsl2dhcn6IasHNWIb118bAhcy23klD29eqgb6UGi5Qs1fLAKLTijrKAJ2Cgdl1MBELS1Yhl25Vdw7Hoi8Acxiv2oCzP0kuy6nm-0xuGv2ebKjHTyyO_3yWKTJRAFHYyTVnmozodIaMHRel9lnyMrRWCJ1uejV4ejaOHHp2Hy2INAH0lxi14M6ydKYZtFNARAlmAd82K4VuCzq6f6Nv2yK_o_OA-mM2JYHtcwTlaXI7-IFfCtDRZeAOnl69CB7QHrM5cr6_d7Z74BT9GxzFqMcczJWoVqGMmNKRL2USujrQIhARoqBEcbws0OPIgEoELuhaJOea-S0llTSd0fx5Mpp2U71IIGy6XImANnEQUzopPe1LhtmNCCK8oGpks_ySsSrIzU2PjU6c0zLTGF9xbF9xjaxXonc5o8d3QvVSHeLCqLPYw8AR-UGT-jWyVg2jOZoai0h1t29lmKn9cvabDMf0H4MM_s9CrmrVTCjia1M9xweyCvPzFOPDo137Y-nvostkHAFfaKphXlAno737vl5BUNWTq9Z63gBcvh_t |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxRBEK4AJuJFRUBXEQvjgcssMz3dsz2JF0Mky2M5GEi4kEl3Ty9ZWWeJu3vAEz9B4z_kl1jd89BFMYTbZrpm0zNTj6-6ur8CeCc5z3k_zQMyQhZwnUSBskkc5JL1U6UoYkl3drh3mHSP-d6JOJmD9_VZmJIfollwc5bh_bUzcLcgvfWbNXTw2bTJmTI-Dw9cR2-fUH1qyKMc1Kk4mMOAUrGk5hUK2VZz62w0-gtiziJWH3J2nsBpPdlyp8l5ezrRbfPtBo_jfZ_mKTyusCh-KJVnCeZs8Qwe9qpq-zL8mFkuxOGoOLu--u58OU78VlpURY7kMilw4YUn6izGOCiQQCW6NXzfrxRHfRza6bn9MlDlHcNLUiG3Lwl9qyOsD5T7wT8oppB83RjD66ufUYqXZJLjFTje-Xi03Q2qFg6B4SziAaVLzJpEp9zYNNY6T0IrrBIqJSCUG0mXFTkdLZgm7ELeRUtpedw32mjXHC1ehYViVNgXgEknlEYJ1qFByuq0jmysOSU4SqR0wbRgs_6Uman4zV2bjWFWMjOzjF5x5l9xC942ohclqce_hNZqfcgqux5nEcWONBYdFrdgoxkmi3RlFlXY0dTLcFf-lfx_MlIQso4i-p_npa41M2EEsV0BnR7Ia8ztU8x297b9j5d3F30Di92j3kF2sHu4_woeEf5LXHEsEmuwMPk6ta8JY030ujelXzgiJAg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKqFeoE9YSum06qGXLInjeB31VAEroAVVVZE4VIpsx6m2LNkVu3ugJ35Cq_5DfknHzgO2L1W9reLJyknm8Y3H_gbgheQ850WaB2SELOBaRIGyIg5yyYpUKYpY0p0dPjwSe8f84CQ5WYBXzVmYih-iXXBzluH9tTPwcV5sXZOGDj6bLvlSxm_BbS5C6VR6533LHeWQTk3BHAaUiYmGVihkW-2t88HoF4Q5D1h9xOmvwMdmrtVGk9PubKq75stPNI7_-TB3YblGovi6Up17sGDL-7B0WNfaH8C3ucVCHI7KT1eXX50nx6nfSIuqzJEcJoUtHHuaznKCgxIJUqJbwffdSnFU4NDOTu3ZQFV3DC9IgdyuJPSNjrA5Tu4HbxBMIXm6CYZXl9-jFC_IICcP4bi_-2F7L6gbOASGs4gHlCwxa4ROubFprHUuQptYlaiUYFBuJF1W5HJ0wjQhF_ItWkrL48Joo11rtPgRLJaj0q4Bil4ojUpYjwYpp9M6srHmlN6oJKULpgMvmy-ZmZrd3DXZGGYVLzPL6BVn_hV34HkrOq4oPX4ntNGoQ1Zb9SSLKHKkcdJjcQeetcNkj67Ioko7mnkZ7oq_kv9NRlL-T1GG_me1UrV2JowAtiuf0wN5hfnzFLP9g23_Y_3fRZ_C0rudfvZ2_-jNY7hD4E-4yliUbMDi9HxmnxDAmupNb0g_ANiLIsA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+long-term+trends+and+recent+patterns+in+the+incidence+of+leukemias+and+lymphomas+among+children+and+adolescents+ages+0-19+years&rft.jtitle=International+journal+of+cancer&rft.au=Linet%2C+Martha+S&rft.au=Brown%2C+Linda+M&rft.au=Mbulaiteye%2C+Sam+M&rft.au=Check%2C+David&rft.date=2016-04-15&rft.issn=1097-0215&rft.eissn=1097-0215&rft.volume=138&rft.issue=8&rft.spage=1862&rft_id=info:doi/10.1002%2Fijc.29924&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon |